Index. D Decision-making capacities, antidepressant, 73 assessment of, 66 68

Transcription

1 A Abandoned dementia, 365 Acetaminophen, 11 Activities of daily living (ADLs), 222 Acute bipolar I depression, pharmacological treatment of, 100 Acute lithium toxicity, 45 Acute manic episodes, 99 Acute stress disorder, Advance care planning (ACP), 69 70, , Advance directives, Advanced cancer, delirium in, 181 Age-related sleep changes, 294 Aging acute and chronic illnesses, 5 7 cardiac conduction system, 15 cardiovascular disease, 12 in central and peripheral nervous system, 7 8 chronic lung and thoracic disorders, 16 cognitive changes, 6 7, 24 examples of, hepatic and renal function, lung disease, 16 pain, perception of, 8 pathophysiology of, 12 pharmacodynamics, 41 pharmacokinetic changes, 17 structural brain changes, Aging Sexual Knowledge and Attitudes Scale (ASKAS), 378 Aid to capacity evaluation (ACE), 69 Alcohol, 132, 138 legal limit for driving, 146 See also Substance use disorder Alzheimer disease acute-onset psychotic disorder, 82 atypical forms of, 217, 218 biomarkers, 211 delirium, 82 diagnosis, , 217, 219 DSM-5 diagnostic criteria, 227 duty to warn criteria, 82 elder abuse, evidenced-based strategies, executive dysfunction, 213 fitness to drive, genetic mutation, initial workup, 82 language, 213 managing patients, 83 neurocognitive disorder due to, 30 neuropsychiatric symptoms, 271 patient management, prevention strategies, 210 psychotic symptoms in, 82 risk factors, 210, , 225 visuospatial, 213 American Associations of Retired Persons (AARP) study, 381 American College of Preventive Medicine (ACPM), 133 American Psychiatric Association (APA) guidelines, 99 Anterior ischemic optic neuropathy, 318 Anticholinergic medications side effects of, 42 psychotropic medications, 42 Antidepressants in bipolar depression, after electroconvulsive therapy, 53 in major depressive disorder, 35 neuropsychiatric symptoms, 277 Antipsychotics, 276 late-life depression, 94 with olanzapine, 14 Springer International Publishing AG, part of Springer Nature 2018 A. Hategan et al., Geriatric Psychiatry Study Guide, 453

2 454 Anxiety disorders, 90 age-specific examples, 112 assessment and management, 117 biological stress response model, 118, 119 clinical history, 116 cognitive impairment, 119, 120 and depressive disorder, diagnosing, , 113, DSM-5 diagnostic criteria, 109, 110 factors causing, 117 fear and, 111, 112 laboratory data, 151 laboratory investigations, 116 in late life, 91, maladaptive avoidance, 111 management, 152 mindfulness-based treatment, 120 MoCA score, 152, 153 physical examination, 116 pragmatic options for, primary vs. secondary, 114 PRN for, 153 rating scales, risk factors, 115 treatment recommendations, 118 Apolipoprotein E epsilon4 (ApoE e4), 223 Asexuality, 384 Atrial fibrillation, older adults, 12 Attention, 26 Atypical Alzheimer disease, 218 Atypical parkinsonism demographic, clinical, and neuropathological features, multidisciplinary approach, 254 neuropathological signatures, 251 vs. Parkinson disease, 252 predictors of survival, 255 treatment, Auditory hallucinations, 103 Autism spectrum disorder diagnosis, 347 DSM-5 diagnostic criteria, 344 retrospective verification, 348 Avoidance, 112 B Beers criteria, 134, 136 BEHAVE-AD Frequency-Weighted Severity Scale (BEHAVE-AD-FW), 271 Behavioral and psychological symptoms of dementia (BPSD), see Neuropsychiatric symptoms Index Behavioral Pathology in Alzheimer s Disease (BEHAVE-AD) scale, Bell s palsy, Benzodiazepine problems associated with, substance use disorder, 137 withdrawal, 146 Bipolar disorder, 96, 98, 103 antidepressants in, 99 cognitive function, 101 psychosis, 103 structural brain abnormalities in, 34 Brain imaging, Brief dynamic therapy (BDT), 56 Burn injury patients differential diagnosis, intervention imperatives, laboratory studies, 148 management, 149 MoCA score, 149 psychiatric differential diagnoses, 148 C Cambridge Cognitive Examination, 249 Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines, 99 Capacity, 65, 69 Cardiac conduction system, age-related changes, 15 Cardiovascular disease, aging, 12 Caregiver Burden Scale (CBS), 440 Caregiver burnout, 433 assessment, care recipients and caregivers, characteristics, 436 causes, 441 compassion fatigue, 440 elder abuse, interventions, 439 prevalence, protective factors, 436 risk factors, 435 symptoms, 434 tools used to measure, Caregiver emotional stress, rating of, 434 Caregiving, prevalence of, Catatonia, antidepressant medications, 171 diagnosis, 170 diagnostic considerations, 169 examination modifications, 169 intervention, 170

3 management, 170 monitoring response, 170 workup, 169 CBT, see Cognitive behavioral therapy (CBT) Central nervous system, age-related changes, 7 Certified public accountant (CPA), 325 Cholinesterase inhibitors, gastrointestinal side effects of, 237 Chronic alcoholism examination, 77 initial thoughts, 77 internal medicine, 78 psychiatric commitment order, 77 Chronic lung and thoracic disorders, aging, 16 Chronic obstructive pulmonary disease (COPD), end-of-life care, 406, 410 Citalopram, 1 Clock-drawing test, 220 Cognition, domains of, Cognitive behavioral therapy (CBT), 54, 55 Cognitive changes, in aging, 24 Cognitive dysfunction, spectrum of, 175 Cognitive enhancers, Cognitive function bipolar disorder, 101 older adults, 12 Cognitive impairment, 203 mild (see Mild cognitive impairment (MCI)) See also specific cognitive impairment Cognitive-behavioral therapy (CBT), hoarding disorder, Cohen-Mansfield Agitation Inventory (CMAI), 270 Communicate CARE, 342 Compassion fatigue, 440 Competence, 65 Computed tomography (CT), for brain imaging, 33 Concentration, 26 Constipation, intellectual disability, 335 Consultation-liaison psychiatrist, 196 Continuous positive airway pressure (CPAP), 299 Corticobasal degeneration, Corticosteroid-induced psychosis, Creatine phosphokinase (CPK), 167 Criminal Code, 63 D Decision-making capacities, antidepressant, 73 assessment of, clinical impression, 72 consultation, 73 essential elements, 73 follow-up, 74 geriatric patients, intervention, 73 oncologist s question, 72 standardized tools, 68 unstable angina, Deep brain stimulation (DBS), 54 Delirium, 72, 103 acute stress disorder and posttraumatic stress disorder from, 193 in advanced cancer, elder abuse, 393 end-of-life care, 411, , geriatric psychiatry, 355 non-pharmacological management, post-stroke delirium, 178 terminal delirium, Delta fibers, 8 Delusional disorder, 103, 104 Dementia, 203 Dementia with Lewy bodies (DLB), 231, 232 Deprescribing, 133 Depressive disorder, 91 anxiety disorders and, 115 elder abuse, end-of-life care, 410, 416 in late-life (see Late-life depression) vs. neurocognitive disorder, preparatory grief, 415 rtms and ECT, 52 Depressive pseudodementia, 90 Dialectical behavioral therapy (DBT), 322 DICE approach, , DiGeorge syndrome critical region 8 (DGCR8), 343 Dimensional model, 311 Dispositional capacity, and patient placement, Divalproex, 99 Dopamine replacement treatment, Down syndrome, 333, 334 major neurocognitive disorder clinical investigations, clinical presentation, differential diagnosis, management strategies, prognosis, psychosocial interventions, neurocognitive disorder, 336 physical features, 335

4 456 Drowsiness, 296 Dyspnea-induced panic symptoms, 420 E Early-onset users, 138 ECT, see Electroconvulsive therapy (ECT) Elder abuse, 389 affect, 392 Alzheimer disease, 398 appearance, 391 assessments, 394 behavior, 391 caregiver behaviors, 392 caregiver burnout, 437 cognitive impairment, 391 delirium, 393 depressive disorder, 400 diagnosis, 395 diagnostic impression, 396 mood, 392 physical and behavioral indicators, physical exam, 392 potential consequences, 390 presentation concerning for, 396 psychiatric treatment, 395 reporting, 393 risk factors, 390 screening tools, 392 signs, 437 speech, 392 thought content, 392 thought process, 392 thyroid replacement, 395 types, vitamin B 12 deficiency, 402 Elder Justice Act, 63 Electroconvulsive therapy (ECT), 366 antidepressants after, 53 contraindications, 50 depressive disorders, 52 mechanism of action, patients with schizophrenia, 51 pharmacological treatment, 53 risks of, 51 Emergency department (ED) in geriatric psychiatry antipsychotics, 361, 362 benzodiazepines, 359 bipolar disorder, 369 boarding of patients, challenges, 351 delirium risk, 355 Index differential diagnosis, 363 differential diagnosis of confusion, environment and clinical focus, 351 exam findings, 365 information for social worker, 364 intravenous benzodiazepines, 360 investigations, 364 long-term care facilities, 353 opioids, 358 paranoid schizophrenia, 366 patients with neurocognitive disorders, 352 pharmacological approaches, 355 psychiatric illness, 353 substance use disorder, 366 suicidal thinking, substance use disorder initial evaluation, 142 mood state, 143 patient management, 143 psychiatric commitment orders, 142 psychiatric management, 143 Emotion Recognition Task (ERT), 231 End-of-life (EOL) care, 405 advance care planning, 408 affecting older patients, 405 antidepressants, chronic obstructive pulmonary disease, , 410 delirium, 411, , depressive disorder, , 416 dying process, 406 dyspnea-induced panic symptoms, 420 emergency department, 183 emotional distress, 415 hospice care, hospice team, impending death, 425 internal medicine physician, 407 major neurocognitive disorder, 428 management strategy, Medicare, 413 medication treatment options for anxiety, 421 neurocognitive disorder, 428 neurological symptoms during the final months, olanzapine, 420 palliative care, 409, patients with advanced cancer, 425 preparatory grief, 415 psychiatric diagnoses, 415 suicidal thoughts, 422

5 terminal delirium, 424 workup, 411 Episodic memory, 24 Epworth Sleepiness Scale, 296 Ethics decision-making capacities, 65 definition, 61 four Cs, 63, 64 informed consent, 64 principles, 61, 62 respect for autonomy, 62 Executive functioning, 27 Exercise, sarcopenia, 19 F Fear, and anxiety disorders, 111 Fear of falling, 110, 113 Five-factor model, Fludrocortisone, 15 Fragile X mental retardation 1 protein (FMRP), 343 Fragile X syndrome, 334, 343 Fragile X-associated tremor/ataxia syndrome (FXTAS), 343, Frailty components of, 4 defining, 3 diagnosing, 3 5 Fried s features of, 3 index, 4 management, 5 multidimensional approach, 4 negative outcomes, 3 unidimensional level, 3 Frontal Assessment Battery (FAB), 230 Frontal Behavioral Inventory (FBI), 230 Frontal lobe syndrome, 369 Frontotemporal lobar degeneration, 233 Frontotemporal neurocognitive disorder, Functional imaging, 32 G Generalized anxiety disorder (GAD), 110, 113, 115, 116 Geriatric disorders, and neurodevelopmental disorders, Geriatric exacerbation, of posttraumatic stress disorder, Geriatric hoarding disorder, 123 Geriatric population 457 common systemic medical and neuropsychiatric conditions, 65, 66 opioid use disorder in, 135 Geriatric-specific anxiety syndromes, 113 H Hallucinations, 104 Health Service Executive Primary Care Reimbursement Service (HSE- PCRS) pharmacy claims database, 136 HELP framework, 342 Hepatic and renal function, aging, 17 Hoarding disorder, 123 differential diagnosis, DSM-5 diagnostic criteria, 123 first-line treatment for, 124 neuropsychological studies, 125 Homicidal patient, involuntary commitment, Hopkins competency assessment tool (HCAT), 69 Hospice and palliative medicine (HPM), 413 Hospice care, 411, 413 palliative care vs., 412 psychotherapy for patients in, 422 House calls teams, supervision of, 197 Hypercalcemia, symptoms and signs, 45 Hypomania, 96 Hypothalamic-pituitary-adrenal (HPA) axis, 120 Hypothyroidism, 177 antipsychotics, 178 assessments, 177 diagnoses, 177 psychotic presentation, 177 thyroid replacement, 178 I Immunosuppressant toxicity, Impaired decisional capacity, 78 Impending death, Informed consent, 64 Insomnia, 305 chronic illnesses andmedications, 306 management, medications, 300 pharmacological treatment, treatment, 307, 308 Instrumental activities of daily living (IADLs), 222 Intellectual ability, 26

6 458 Intellectual disability, 333 age-related physiological changes, 333 constipation, 335 DSM-5 diagnostic criteria, 334 genetic causes, 334 Internal medicine, 78 The International Society to Advance Alzheimer s Research and Treatment (ISTAART), 205 Interpersonal therapy (IPT), 54 Involuntary commitment, 71 homicidal patient, suicidal patient, L Lancet Commission on Dementia Prevention, Intervention, and Care, 223 Language skills, 26 Late-life anxiety, 116 biological stress response model, cognitive impairment, laboratory investigations, 116 Late-life bipolar disorder, 96 Late-life depression acute management, antipsychotics, anxiety, diagnosis, 93 earlier onset depression, mania and hypomania, mild cognitive impairment, 207 prevalence of, 90 psychosis, reportable conditions for risk, and risk of vascular neurocognitive disorder, 228 secondary mania, 97 structural neuroimaging changes in, suicide risk factors, Late-life neuropsychiatric symptoms, 206 Late-life psychosis, risk factors for, 104 Late-onset schizophreniform disorder, 103 Late-onset users, 138 Legal issues, 63 Level of consciousness (LOC), 148 Lewy body disease, 29 30, 233 Lithium, 99 side effects and risks, Lorazepam, 281 Lung disease, aging, 16 Index M MacArthur competency assessment tool for treatment (MacCAT-T), 69 Magnetic resonance imaging (MRI) for brain imaging, 33 contraindications for, 32 structural brain changes, 23 Major depressive disorder, antidepressant treatment in, 35 clinical characteristics, 209 comorbid disorders in, 91 defining, 89 driving risk, 95 DSM-5 diagnostic criteria, 89 prevalence of, 90 primary diagnosis of, 93 symptom in older patients, 90 treatment of, 94 Major neurocognitive disorder, 164, 169, 172, 174, 180, 183, 185, 186, 191, 192 characteristics, 233 cognitive domains affected in, 233, 234 dementia with Lewy bodies, depressive disorder vs., 171 DICE approach, differential diagnosis, 233, 234 Down syndrome clinical investigations, 338 clinical presentation, 336 differential diagnosis, 337 management strategies, 340 prognosis, 339 psychosocial interventions, 341 post-stroke delirium and, 178 sexuality, 383 types, 232 Maladaptive avoidance, 111, 112 Mania, 96 Manic episode, 96 vs. primary psychotic disorder, 98 Marijuana smokers, pharmacological treatment, provisional diagnosis, 105 MBI, see Mild behavioral impairment (MBI) Medical assessment, components of, 2 Medication compliance, practical suggestions, Medication-induced psychotic disorder, 103 Memory, 26 encoding, 24 processes, 24 retrieval, 25 storage, 25

7 Methamphetamine abuse antidepressants, 156 diagnosis, 155 diagnostic possibilities, 154 exam findings, management, 155 medical evaluations and laboratory studies, 154 psychostimulant withdrawal, 155 Middelheim Frontality Scale (MFS), 231 Mild behavioral impairment (MBI) checklist domains and question topics, 287 ISTAART Research Diagnostic Criteria for, 205 significance, Mild behavioral impairment checklist (MBI-C), Mild cognitive impairment (MCI), 203 classification, 204 conversion rate, 207 late-life depressive disorders, late-life neuropsychiatric symptoms, neurocognitive disorders, 206 neuropsychiatric symptoms in, 273 Mild neurocognitive disorder, see Mild cognitive impairment (MCI) Mindfulness-based stress reduction (MBSR), 120 Mini-Mental State Examination (MMSE), 25, 220 Mirtazapine, 300 Montreal Cognitive Assessment (MoCA), 2, 25, 72, 74, 75, 77, 220, 231, 249 Mood episode, Motor skills, 26 Movement disorder, treatment, 254 Multiple system atrophy, N Narrative-based ethics, 63 Neurocognitive disorder due to Alzheimer disease, 30 clinical characteristics, 209 diagnosis of, 25 diagnostic criteria, 210 differential diagnosis, with Lewy bodies, 29 mild cognitive impairment, 206 neuropsychological predictors, post-stroke delirium and, 178 with psychosis, See also specific neurocognitive disorders Neurodevelopmental disorders, 342 Neuroimaging, 32 Neuroleptic malignant syndrome, antipsychotic treatment, 167 delirium laboratory studies, 167 diagnosis, 167 diagnostic considerations, 166 features of, 46 management, 167 management of post-nms patients, 168 routine monitoring, 166 vs. serotonin syndromes, 165 Neuropsychiatric Inventory (NPI), 270 Neuropsychiatric symptoms agitation, 275, Alzheimer disease, antidepressants, 277 antipsychotic medications, apathy, 274 behavioral symptoms, 275 capacity to consent to treatment, in cognitively normal individuals, consequences, 285 delusional symptoms, 281 DICE approach, early stages, lorazepam, 281 management plan, in mild neurocognitive disorders, neuroimaging fingings, non-pharmacological strategies, non-pharmacological therapies, patient considerations in investigate step, 282 pharmacological interventions, prevalence, 269, 271, 272 sleep disorders, 284 valproic acid, Neuropsychological assessment, 25, 26, Neuropsychological predictors, 28 Neuropsychological testing, 26, 27 Non-pharmacological strategies, 283 Non-pharmacological therapies, 279 O Obsessive-compulsive disorder (OCD), 121, 122, Obsessive-compulsive personality disorder, 327, 328 Occipital cortex, 23

8 460 Olanzapine, 14, 411 antipsychotic therapy with, 14 end-of-life care, 420 Older adults atrial fibrillation and cognitive function, 12 chronic pain, 10 pain management, pain rating scales, 9 10 psychotherapy in, 54 Older Americans Act, 63 Opioids geriatric population, 135 geriatric psychiatry, non-psychiatric symptoms, 358 Orthostatic hypotension defining, management, medications, 14 P Pain age-related changes, 8 management, 10 rating scales, 9 signs/behaviors, 11 Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC), 10 Pain Assessment in Advanced Dementia Scale (PAINAD), 10 Palliative care demoralization, grief, and depression in, 417 end-of-life care, 409 vs.hospice care, 412 medication management, medication treatment options for anxiety, 421 psychotropic medication, 423 Panic disorder, 114 Paranoid schizophrenia, 74, 366 delusions, 76 disposition, 76 exam findings, 75 initial workup, legal status, 76 Parkinson disease American Academy of Neurology guidelines, 250 bradykinesia, 245 clinical features, 249 dopamine replacement treatment, 254 features, Index identification of nonmotor symptoms of, multidisciplinary approach, 254 neuropathological signatures, neuropsychiatric symptoms, nonmotor features, 247 phenotypic syndromes, prevalence, 243 progression, rigidity, 245 symptoms, treatment, 253 tremor, 244 Paroxetine, 127 Patient placement, dispositional capacity, Perceived Caregiver Burden Scale (PCBS), 440 Periodic limb movement disorder, 297, 298 Peripheral nervous system, age-related changes, 7 Personality disorders, 311 agreeableness, 316 anterior ischemic optic neuropathy, cardinal feature, 314 challenges in diagnosing older adults, 314 classification, 313 conceptualizing, conscientiousness, 316 delirium, 317 depression, 325 differential diagnosis, DSM-5, extraversion, 316 five-factor model, 315, 316 geriatric population, 315 internal medicine, involuntary inpatient psychiatric admission, medical risks, 319 misconceptions constituting barriers, 315 neuroticism, 316 normal personality, 312 older patients with, 317 openness to experiences, 316 prevalence of, 313 psychiatric differential diagnoses, psychosis and mania, rheumatologic illness, 318 treatment, 329 Pharmacodynamics, 41 Pharmacokinetic changes, aging, 17 Pharmacotherapy, 50, 51, 53, 127

9 Phobias, 109, 113 Physician leadership, 443 actions and skills, 451 characteristics, 443 constructs, 444 empathy, 450 enthusiasm, 450 government agency, 448 integrity, 449 interprofessional collaboration, 450 large organization, 447 listening and communication skills, 449 and management, 445 middle-sized organization, 446 optimism, 450 qualities for, 449 residency redesign, 451 small organization, 445 styles, 445, 450 transformational leadership, 444 vision, 449 Pimavanserin, 249 Polypharmacy, 13, 39, 133 Beers criteria, 134 medication classes, 40 prevalence of, substance use disorder, 133 Positron emission tomography (PET), 28, 35 Posterior cortical atrophy, Post-stroke delirium, Posttraumatic stress disorder (PTSD), 111 Checklist-Civilian version, 111 from delirium, 193 DSM-5 diagnostic components, 126 geriatric exacerbation of, 195 medications for, 127 pharmacotherapy for, Primary Care PTSD Screen for DSM-5, 111 recurrent, 197 risk factors for, short screening scale for, 111 Potentially inappropriate medication (PIM), 41 Potentially inappropriate prescribing (PIP), 136 Preparatory grief, 415 Prescription, misuse and abuse, 134, 135 Primary Care PTSD Screen for DSM-5 (PC-PTSD-5), 111 Primary psychotic disorder, manic episode vs., 98 Problem-solving therapy (PST), 55 Processing speed, 24 Progressive supranuclear palsy, Progressive supranuclear palsy-parkinsonism, 246 Protecting Canada s Seniors Act, 63 Pseudodementia, 101 Psychosis, 98, 103 Psychostimulant use disorder, 148, 150 Psychotherapy, 43, Psychotic disorder, 103 Psychotropic medications, PTSD, see Posttraumatic stress disorder (PTSD) Q QT prolongation, 48 R Recurrent posttraumatic stress disorder, 197 REM sleep behavior disorder, 297 Reminiscence therapy, 56 Renal failure, 173 clinical implications, 176 delirium precautions, 176 diagnosis, dialysis, 176 evaluation, 174 nephrologist, patient s current state, 175 psychiatric diagnosis, Repetitive transcranial magnetic stimulation (rtms) adverse effects, 53 depressive disorders, 52 Respect for autonomy, 62 Restless legs syndrome, 297, 298 Rhabdomyolysis, 46, 47 Richardson syndrome, 246 Richmond Agitation and Sedation Scale (RASS), 400 Rivastigmine, 250 rtms, see Repetitive transcranial magnetic stimulation (rtms) S Sarcopenia defining, 18 factors contributing, 19 long-term outcomes of, therapeutic options in, 19 Schizophrenia, 14 ECT in, electroconvulsive therapy, 51 treatment options for, 106

10 462 Screening Tool of Older Person s Prescriptions and Screening Tool to Alert doctors to Right Treatment (STOPP/ START) criteria, Secondary mania, 97 Selective serotonin reuptake inhibitor (SSRI), 1, 43 Semantic memory, 24 Serotonin syndrome, 47, 163 diagnosis, diagnostic probabilities, 164 laboratory studies, 164 management, managing sleep, neuroleptic malignant vs., 165 signs and symptoms, 165 Sexual Behavior Questionnaire (SBQ), 378 Sexual dysfunction, 379, 382 Sexuality age-associated changes, 376 barriers, 382 decisional capacity assessment, 386 factors affecting, 380 history taking in older adults, interviewing questions for older adults, 378 long-term care facility residents, major neurocognitive disorders, management, 383 normative age-associated changes, PLISSIT model, 379 positive predictors, sexual response cycle, 375, 376 Short Post-Traumatic Stress Disorder Rating Interview (SPRINT), 111 Single-photon emission computed tomography (SPECT), 36 Sleep disorders, Sleep-disordered breathing, 297 Sleep-wake disorders adverse consequences, 293 age-related sleep changes, 294 chronic illnesses associated with, 306 clinical diagnosis, 295 common age-related physiological changes, 293, 294 neuropsychiatric disorders, 296 non-pharmacological strategies, in older adults, 294, 295 prevalence, 297, 298 types, Somatic delusion, Somatic symptoms, 94 Index SPAN, screening tools, 111 SSRI, see Selective serotonin reuptake inhibitor (SSRI) Staff Attitudes about Intimacy and Dementia (SAID) questionnaire, Structural imaging, 32 Substance use disorder, 56 57, 142, 143 abused/misused drugs, alcohol withdrawal delirium, 145 antipsychotics, 147 Beers criteria, 136 benzodiazepine, 137 categories of, 138 characteristics, 144 chart review, 140 clinical consequences of, 134 complications, definition, 131 development of, diagnosis, 141 diagnostic possibilities, 145 drinking guidelines, emergency department initial evaluation, 142 mood state, 143 patient management, 143 psychiatric commitment orders, 142 psychiatric management, 143 formal interview/mental status testing, geriatric population, 135 geriatric substance use, 139 interventions, 141 low social function, maintenance medications for, 150 major assumptions, management, 147 medical and psychiatric problems, 132 minimum laboratory panel, 145 polypharmacy, potentially inappropriate prescribing, 136 prescription drugs, 134 prevalence of, 131 psychotherapy, 141 screening tools, symptoms, 145 trends in, 138 Suicide risk additional workup, 84 antidepressants, 85 differential diagnosis, 84 ethical tension, highest-risk patients, involuntary commitment, 83 86

11 463 laboratory results, 85 late-life depression, 93 managing patient, 85 risk factors, 85 Supervision of house calls teams, T TBI, see Traumatic brain injury (TBI) Terminal delirium, 182 Testosterone, 19 Tilburg frailty indicator (TFI), 4 5 Torsades de pointes (TdP), 48 Trail Making Test (TMT), 220, 221 Transformational leadership, 444 Transient ischemic attack (TIA), 121 Trauma Screening Questionnaire (TSQ), 111 Traumatic brain injury (TBI)course of recovery from, 264 depression after, emergency department, 263 external cause, 264 long-term cognitive impairment, 262 and major neurocognitive disorder, 262 Mayo classification system, 265 mechanisms for, 264 neuropsychiatric symptoms, 261 in older adults, 263 Trazodone, 300 U Understanding treatment disclosure (UTD), 69 Unstable angina cause of, 79 considerations, 79 data, 80 decision-making capacities, 80 exam findings, 80 psych history, surgical colleague, 81 V Valproic acid, neuropsychiatric symptoms, 277 Vascular cognitive impairment, 233 Vascular neurocognitive disorder, 227 DSM-5 diagnostic criteria, frontotemporal, 230 late-life depression and, 228 risk factors for, 229 treatment of, Visual spatial skills, 26 Vitamin B 12 deficiency, , 402 W Wechsler Adult Intelligence Scale (WAIS), 26 Wisconsin Card Sorting Test (WCST), Y Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Year of added competence (YAC), 413 Z Zarit Burden Interview (ZBI), 439